Show simple item record

dc.contributor.authorWebb, Aen
dc.contributor.authorMadgett, Ten
dc.contributor.authorMiran, Ten
dc.contributor.authorSillence, Ken
dc.contributor.authorKaushik, Nen
dc.contributor.authorKiernan, Men
dc.contributor.authorAvent, Nen
dc.date.accessioned2018-08-13T14:59:19Z
dc.date.available2018-08-13T14:59:19Z
dc.date.issued2012-12en
dc.identifier.issn1311-0160en
dc.identifier.urihttp://hdl.handle.net/10026.1/12113
dc.description.abstract

Current invasive procedures [amniocentesis and chorionic villus sampling (CVS)] pose a risk to mother and fetus and such diagnostic procedures are available only to high risk pregnancies limiting aneuploidy detection rate. This review seeks to highlight the necessity of investing in non invasive prenatal diagnosis (NIPD) and how NIPD would improve patient safety and detection rate as well as allowing detection earlier in pregnancy. Non invasive prenatal diagnosis can take either a proteomics approach or nucleic acid-based approach; this review focuses on the latter. Since the discovery of cell free fetal DNA (cffDNA) and fetal RNA in maternal plasma, procedures have been developed for detection for monogenic traits and for some have become well established (e.g., RHD blood group status). However, NIPD of aneuploidies remains technically challenging. This review examines currently published literature evaluating techniques and approaches that have been suggested and developed for aneuploidy detection, highlighting their advantages and limitations and areas for further research.

en
dc.format.extent17 - 26en
dc.languageengen
dc.language.isoengen
dc.subjectAneuploidyen
dc.subjectCell free fetal DNA (cff DNA)en
dc.subjectNon invasive prenatal diagnosis (NIPD)en
dc.titleNon invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment?en
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/24052738en
plymouth.issueSupplen
plymouth.volume15en
plymouth.publication-statusPublisheden
plymouth.journalBalkan J Med Geneten
dc.identifier.doi10.2478/v10034-012-0013-zen
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Biomedical Sciences
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Professional Services staff
dc.publisher.placePolanden
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.2478/v10034-012-0013-zen
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV